Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
Our Clinicians and Researchers
Irena Nulman, MD, FRCPC Neurology, PhD (C)
Professor of Paediatrics, University of Toronto
Staff, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children
Director, Fetal Alcohol Syndrome Clinic
Associate Director, Motherisk Program
University of Toronto Fellowship Program Director, Clinical Pharmacology
Associate Scientist, Child Health Evaluative Sciences (CHES), Research Institute
Dr. Nulman is an associate professor in the Department of Paediatrics at the University of Toronto; staff pharmacologist at the Division of Clinical Pharmacology and an associate director of the Motherisk Program at The Hospital for Sick Children. Dr. Nulman graduated from Ternopol Medical School in Ukraine, where she completed her residency in internal diseases. Following her residency she emigrated to Israel and completed training in neurology, specializing in neuropharmacology, and serving as a staff neurologist at Carmel Hospital, Technion Haifa. Subsequently, she received her training in pharmacology, teratology and reproductive toxicology at the Division of Clinical Pharmacology and the Motherisk Program at The Hospital for Sick Children in Toronto, Canada.
Dr. Nulman is an expert in the behavioural teratology of psychotropic drugs (anticonvulsants, antidepressants, antiemetics), immunosuppressive drugs, medications used for the treatment of maternal cancer, and the in-utero effects of drug of abuse. Currently, her main interest is in the effects of prenatal alcohol exposure on the child's postnatal achievements, telediagnosis, and development of diagnostic psychological markers for children with fetal alcohol spectrum disorder.
Dr. Nulman works in close association with the Children's Aid Societies providing scientific information on children with regards to prospective adoptions. She contributed extensively to the literature in behavioural teratology and is an author and co-author a number of ground-breaking publications on these topics. She is an associate scientist in Child Health Evaluative Sciences (CHES) for the Research Institute at The Hospital for Sick Children and the site program director for the Postgraduate Medical Training Program in Clinical Pharmacology at the University of Toronto.












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)